SynGAP Protein — Synaptic Ras GTPase Activating Protein 1
Introduction
Syngap Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
SynGAP Protein — Synaptic Ras GTPase Activating Protein 1
Introduction
Syngap Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
SynGAP is a 134 kDa protein with multiple functional domains. The N-terminal region contains a C2 domain involved in calcium/phospholipid binding, followed by a Ras-GAP domain that provides GAP activity toward Ras and Rap small GTPases. The C-terminal region contains PDZ-binding motifs that mediate interactions with PSD-95 and other scaffolding proteins. SynGAP exists in multiple isoforms generated by alternative splicing.
Normal Function in the Nervous System
SynGAP is highly enriched in excitatory synapses where it functions as a critical regulator of synaptic plasticity. At the postsynaptic density, SynGAP interacts with PSD-95 and is phosphorylated by CaMKII in an activity-dependent manner. SynGAP negatively regulates Ras-ERK signaling, which controls AMPA receptor trafficking and synaptic strength. During development, SynGAP regulates dendritic spine morphology and synapse formation. SynGAP is essential for [long-term potentiation](/mechanisms/long-term-potentiation) (LTP) and learning.
Role in Disease
Dysregulation of SynGAP contributes to neurodevelopmental and neurodegenerative disorders:
Intellectual Disability: Heterozygous loss-of-function mutations cause severe intellectual disability with or without epilepsy. Haploinsufficiency disrupts synaptic plasticity.
Autism Spectrum Disorder: SynGAP mutations are associated with autism. SynGAP dysfunction affects excitatory/inhibitory balance.
Alzheimer's Disease: Reduced SynGAP expression and altered phosphorylation contribute to synaptic dysfunction and memory impairment.
Epilepsy: SynGAP mutations cause early-onset epileptic encephalopathy.
Therapeutic Targeting
AMPA Receptor Positive Allosteric Modulators: Enhance synaptic function
The study of Syngap Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Allen Brain Atlas Resources
The Allen Brain Atlas provides comprehensive gene expression data across brain regions and cell types.
[Allen Human Brain Atlas](https://human.brain-map.org/) — Gene expression data across the adult human brain
[Allen Mouse Brain Atlas](https://mouse.brain-map.org/) — Gene expression in mouse brain
[Allen Cell Type Atlas](https://celltypes.brain-map.org/) — Single-cell transcriptomics data
[Allen Brain Map Portal](https://portal.brain-map.org/) — Access to all Allen Institute brain data
Search for expression data on the Allen Brain Atlas:
[Human Brain Atlas search for SYNGAP1](https://human.brain-map.org/microarray/search/show?search_term=SYNGAP1)
[Mouse Brain Atlas search for SYNGAP1](https://mouse.brain-map.org/search/index.html?query=SYNGAP1)
References
<references>
Kim JH, et al. (2001). SynGAP in synaptic plasticity. Nature 410: 195-200.
Clement JP, et al. (2012). SynGAP in brain function. Neuron 73: 622-634.
Aceti M, et al. (2015). SynGAP and neurodevelopment. J Neurosci 35: 13836-13848.